What You Missed at the 2nd Cell Therapy Analytical Development Summit Europe 2023
Uncovering New Disruptive Technologies & Innovations to Accelerate Analytical Methods, Accurately Measure Potency & Support Seamless Regulatory Submissions
The new and improved 2nd Cell Therapy Analytical Development Summit Europe returned as your go-to meeting to address key regulatory hurdles and developing standards for assay and analytical development in the European cell therapy market.
What you missed:
- Maximising the speed of quality control, implement automation, improve characterisation of potency, safety and product
- Developing robust, reliable, and in-depth analytical assays
With a focus on critical analytical parameters and quality control, the 2nd Cell Therapy Analytical Development Summit Europe offered valuable insights on optimising manufacturing processes and ensuring regulatory compliance. Spanning a variety of cell therapy modalities, analytical techniques, and strategic approaches, this was a must-attend meeting for anyone in the cell therapy analytical space - brought right to your doorstep!
Learn to develop a successful potency assay to determine product activity
Discover new technology to expand & improve your analytical toolbox
Explore reference standards for state-of-the-art analytical development
Gain insights on optimising manufacturing processes & ensuring regulatory compliance
Network with CMC, analytical & quality experts from industry & regulatory agencies
Analytical experts from industry and regulatory agencies collaborated and shared solutions to pressing challenges, ranging from understanding the evolving regulatory landscape to innovative analytical methods that accelerate the product lifecycle.
The 2nd Cell Therapy Analytical Development Summit Europe was the ideal event for companies looking to achieve a robust and thorough analytical strategy, helping to get invaluable cell therapies to patients faster.
For more details about the 2023 program, and speaker faculty download the brochure.